Related references
Note: Only part of the references are listed.Association of Estimated GFR With Platelet Inhibition in Patients Treated With Clopidogrel
Clotilde Muller et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Clinical Predictors of High Posttreatment Platelet Reactivity to Clopidogrel in Koreans
Kyung Woo Park et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study
Jong Shin Woo et al.
AMERICAN HEART JOURNAL (2011)
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
Olivier Morel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel Results from PRINCIPLE-TIMI 44
Andrew L. Frelinger et al.
THROMBOSIS AND HAEMOSTASIS (2011)
The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent
Thomas Gremmel et al.
THROMBOSIS RESEARCH (2011)
Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry
Caroline S. Fox et al.
CIRCULATION (2010)
Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Hospital Performance and Differences by Kidney Function in the Use of Recommended Therapies After Non-ST-Elevation Acute Coronary Syndromes
Uptal D. Patel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity
Thomas Gremmel et al.
ATHEROSCLEROSIS (2009)
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study
Marco Valgimigli et al.
CIRCULATION (2009)
Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay A 12-Month Follow-Up
Rossella Marcucci et al.
CIRCULATION (2009)
Acute coronary syndrome in ESRD patients
Sikander P. Surana et al.
KIDNEY INTERNATIONAL (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
Matthew J. Price et al.
EUROPEAN HEART JOURNAL (2008)
Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo
David Erlinge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin
Martine Gilard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary
B. Linnemann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Aspirin 'resistance': role of pre-existent platelet reactivity and correlation between tests
A. L. Frelinger et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Measuring antiplatelet drug effects in the laboratory
Paul Harrison et al.
THROMBOSIS RESEARCH (2007)
Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement
Willibald Hochholzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
Tobias Geisler et al.
EUROPEAN HEART JOURNAL (2006)
Outcomes after percutaneous coronary interventions in patients with CKD: Improved outcome in the stenting era
C Stigant et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
WH Chen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Predictors of new-onset kidney disease in a community-based population
CS Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
PA Gum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
PA Gum et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Share Paper
